Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India
February 14, 2019Mumbai/Cape Town - Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline. Nandita...
Read more
Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India
February 8, 2019Mumbai/Cape Town - Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline....
Read more
Renewed hope- Stories of four patients fighting drug-resistant-TB in Mumbai
March 24, 2018Name : Designation : Interviews conducted & written by DVL Padma Priya for MSF For World TB Day 2018, we celebrate the courage and endurance of four MSF patients who are currently undergoing treatment for drug-resistant TB (DR-TB). Pooja,...
Read more
Mumbai: A new life with new tuberculosis drugs
December 1, 2016Increasingly drug-resistant strains of tuberculosis (TB) are on the rise in India, particularly in hotspots such as Mumbai. Two new TB drugs, bedaquiline and delaminid, show promising results and offer renewed hope to patients whose TB strains are resistant to...
Read more
India: Renewed hope with new drugs
October 28, 2016Two new drugs, bedaquiline and delamanid, are proving to be the very last lifeline for tuberculosis (TB) patients with the most extreme forms of drug resistance. While a few patients benefit from these new drugs in India, many die before being able...
Read more
